| Model NO.: | |
|---|---|
| Form: | |
| Color: | |
| Quantity: | |
100units
botulax
| Product Advantage |
Botox has a longer effect, better wrinkle removal effect, and is less susceptible to side effects and drug resistance than other Botox toxins.
1. Facial wrinkle removal: The effect after gravity wrinkle surgery is long-term; it is suitable for dynamic wrinkles such as forehead lines, vertical lines between eyebrows, and horizontal lines at the base of the nose.
2. Eyebrow plastic surgery: Correct eyebrow asymmetry and flatten the periphery of the oral cavity. Oral angular plastic surgery.
3. Face Slim and Legs: For those who have big muscles on the face and developing calf muscles, the effect of thinning the face and thinning the calf. .
Technical Parameters
| unit | 100U |
| application | Small areas (e.g. forehead, crow's feet) |
| Length of time | 5-6 months |
| cost | Suitable for small-scale treatments, affordable |
| Suitable for | Delicate areas (around the eyes, corners of the mouth) |
Product Uses
1. Mechanism of Action
Botulax exerts its therapeutic effects through selective neuromuscular modulation. By inhibiting acetylcholine exocytosis at synaptic clefts, it induces temporary paralysis of targeted musculature and suppression of glandular activity, with fully reversible outcomes.
2. Aesthetic Medicine Applications
• Facial Rejuvenation:
- Dynamic rhytid reduction: Addresses glabellar lines, periocular wrinkles, and frontal creases
- Lower facial sculpting: Achieves masseter volume reduction for V-line contouring and mandibular definition
- Expression refinement: Corrects oral commissure ptosis and excessive gingival display
• Body Contouring:
- Calf recontouring: Creates graceful lower limb proportions through gastrocnemius attenuation
- Hyperhidrosis management: Controls pathological sweating in axillary and palmar regions
3. Therapeutic Indications
• Neurological Disorders:
- Ocular muscle dystonia (blepharospasm)
- Focal facial dystonias
- Prophylactic migraine management
- Cervical dystonia treatment
• Urological Applications:
- Detrusor muscle hyperactivity control
4. Pharmacodynamic Profile
- Latency period: Initial effects manifest within 48-72 hours
- Peak efficacy: Optimal results observable at 7-14 days post-administration
- Duration: Therapeutic window typically spans 16-24 weeks
- Safety profile: Neural transmission restoration occurs through natural axonal sprouting
FAQ
Q1: What is the primary active component in Botulax and its mechanism of action?
A: Botulax contains purified neurotoxin type A as its core ingredient. This biological agent functions by selectively interrupting synaptic transmission through inhibition of acetylcholine release at peripheral nerve terminals, resulting in temporary relaxation of targeted musculature and suppression of glandular activity. The neuromodulatory effects gradually diminish as new nerve terminals regenerate over a typical 16-24 week period.
Q2: How does Botulax compare to Botox in terms of clinical performance and ethnic suitability?
A: While both formulations utilize type A botulinum toxin, Botulax distinguishes itself through:
- Superior purification yielding 99.5% active neurotoxin with minimal protein load
- Optimized molecular configuration demonstrating 5mm diffusion radius for precision treatments
- Enhanced compatibility with Asian facial anatomy due to tailored dosing protocols
These characteristics position it as a preferred therapeutic alternative in cost-sensitive markets.
Q3: What is the expected onset and duration of clinical effects following administration?
A: Patients typically observe initial clinical effects within 48-72 hours post-treatment, with peak therapeutic outcomes becoming apparent by days 7-14. The duration of effect shows interpatient variability but generally persists for 4-6 months in most clinical applications. Maintenance therapy at appropriate intervals can prolong therapeutic benefits.
| Product Advantage |
Botox has a longer effect, better wrinkle removal effect, and is less susceptible to side effects and drug resistance than other Botox toxins.
1. Facial wrinkle removal: The effect after gravity wrinkle surgery is long-term; it is suitable for dynamic wrinkles such as forehead lines, vertical lines between eyebrows, and horizontal lines at the base of the nose.
2. Eyebrow plastic surgery: Correct eyebrow asymmetry and flatten the periphery of the oral cavity. Oral angular plastic surgery.
3. Face Slim and Legs: For those who have big muscles on the face and developing calf muscles, the effect of thinning the face and thinning the calf. .
Technical Parameters
| unit | 100U |
| application | Small areas (e.g. forehead, crow's feet) |
| Length of time | 5-6 months |
| cost | Suitable for small-scale treatments, affordable |
| Suitable for | Delicate areas (around the eyes, corners of the mouth) |
Product Uses
1. Mechanism of Action
Botulax exerts its therapeutic effects through selective neuromuscular modulation. By inhibiting acetylcholine exocytosis at synaptic clefts, it induces temporary paralysis of targeted musculature and suppression of glandular activity, with fully reversible outcomes.
2. Aesthetic Medicine Applications
• Facial Rejuvenation:
- Dynamic rhytid reduction: Addresses glabellar lines, periocular wrinkles, and frontal creases
- Lower facial sculpting: Achieves masseter volume reduction for V-line contouring and mandibular definition
- Expression refinement: Corrects oral commissure ptosis and excessive gingival display
• Body Contouring:
- Calf recontouring: Creates graceful lower limb proportions through gastrocnemius attenuation
- Hyperhidrosis management: Controls pathological sweating in axillary and palmar regions
3. Therapeutic Indications
• Neurological Disorders:
- Ocular muscle dystonia (blepharospasm)
- Focal facial dystonias
- Prophylactic migraine management
- Cervical dystonia treatment
• Urological Applications:
- Detrusor muscle hyperactivity control
4. Pharmacodynamic Profile
- Latency period: Initial effects manifest within 48-72 hours
- Peak efficacy: Optimal results observable at 7-14 days post-administration
- Duration: Therapeutic window typically spans 16-24 weeks
- Safety profile: Neural transmission restoration occurs through natural axonal sprouting
FAQ
Q1: What is the primary active component in Botulax and its mechanism of action?
A: Botulax contains purified neurotoxin type A as its core ingredient. This biological agent functions by selectively interrupting synaptic transmission through inhibition of acetylcholine release at peripheral nerve terminals, resulting in temporary relaxation of targeted musculature and suppression of glandular activity. The neuromodulatory effects gradually diminish as new nerve terminals regenerate over a typical 16-24 week period.
Q2: How does Botulax compare to Botox in terms of clinical performance and ethnic suitability?
A: While both formulations utilize type A botulinum toxin, Botulax distinguishes itself through:
- Superior purification yielding 99.5% active neurotoxin with minimal protein load
- Optimized molecular configuration demonstrating 5mm diffusion radius for precision treatments
- Enhanced compatibility with Asian facial anatomy due to tailored dosing protocols
These characteristics position it as a preferred therapeutic alternative in cost-sensitive markets.
Q3: What is the expected onset and duration of clinical effects following administration?
A: Patients typically observe initial clinical effects within 48-72 hours post-treatment, with peak therapeutic outcomes becoming apparent by days 7-14. The duration of effect shows interpatient variability but generally persists for 4-6 months in most clinical applications. Maintenance therapy at appropriate intervals can prolong therapeutic benefits.
